$400 Million is the total value of Medicxi Ventures Management (Jersey) Ltd's 7 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $204,075,000 | -31.8% | 18,123,892 | +1.1% | 51.07% | -21.6% |
| New | AURA BIOSCIENCES INC | $51,617,000 | – | 3,039,892 | +100.0% | 12.92% | – | |
| MRUS | MERUS N V | $50,880,000 | +44.5% | 1,600,000 | 0.0% | 12.73% | +66.3% | |
| PCVX | VAXCYTE INC | $44,903,000 | -6.2% | 1,887,478 | 0.0% | 11.24% | +7.9% | |
| PHAT | PHATHOM PHARMACEUTICALS INC | $40,675,000 | -38.7% | 2,067,861 | 0.0% | 10.18% | -29.5% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $4,310,000 | -27.7% | 1,501,716 | 0.0% | 1.08% | -16.8% | |
| OBSV | OBSEVA SA | $3,124,000 | -36.0% | 1,570,000 | 0.0% | 0.78% | -26.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Francesco De Rubertis #1
- Kevin Stuart Johnson #2
- Michele Ollier #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PHATHOM PHARMACEUTICALS INC | 16 | Q3 2023 | 69.8% |
| MERUS N V | 16 | Q3 2023 | 25.3% |
| VAXCYTE INC | 14 | Q3 2023 | 44.5% |
| OBSEVA SA | 12 | Q3 2022 | 5.7% |
| CENTESSA PHARMACEUTICALS PLC | 10 | Q3 2023 | 71.3% |
| AURA BIOSCIENCES INC | 8 | Q3 2023 | 22.9% |
| CHECKMATE PHARMACEUTICALS IN | 8 | Q2 2022 | 12.7% |
| NEWAMSTERDAM PHARMA COMPANY | 4 | Q3 2023 | 11.4% |
| SYNTHORX INC | 1 | Q4 2019 | 43.1% |
View Medicxi Ventures Management (Jersey) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-15 |
| 13F-HR | 2024-02-01 |
| 3 | 2024-01-26 |
| 13F-HR | 2023-10-18 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-25 |
| 13F-HR/A | 2022-08-03 |
| 13F-HR | 2022-08-03 |
View Medicxi Ventures Management (Jersey) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.